Status:
COMPLETED
Functional Remediation for Bipolar Disorder
Lead Sponsor:
University of Michigan
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to ...
Eligibility Criteria
Inclusion
- diagnosis of bipolar I or II disorder (BD), as determined by a structured diagnostic interview
- at least three months of clinical remission (euthymia or minimal symptoms), based on the phone screen assessing mood episodes in the prior three months
- score greater than 11 on a measure of everyday functioning (FAST; described in measures section) indicating at least mild impairment
- use of a standard bipolar mood-stabilizing medication at the same, adequate dose (according to CANMAT treatment guidelines) for at least 3 months prior to screening, with ability to continue that dose during the study.
Exclusion
- history of neurological illness or injury (e.g., stroke, brain tumor)
- documented intellectual disability
- inability to provide written informed consent
- substance dependence within last 3 months or substance abuse in last 30 days
- inability to complete the six-month intervention
- received ECT in the past 12 months
Key Trial Info
Start Date :
November 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03403179
Start Date
November 17 2017
End Date
December 20 2018
Last Update
February 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Depression Center
Ann Arbor, Michigan, United States, 48109